肌缩侧面硬化症相关遗传变异的发生率:基于临床的临床研究
Nan Hu1, Lei Zhang1, Dongchao Shen1
1Department of Neurology, Peking Union Medical College and Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100730, China.
概括
超过一半的肌缩性侧面硬化症 (ALS) 患者携带基因变异,病原性/可能病原性变异在家族性ALS中更为常见. 基因测试指标,如早期发病或认知衰退,对变种检测率没有显著影响.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 医学研究 医学研究
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病.
- 识别遗传因素对于了解ALS病因和开发向治疗至关重要.
- 之前的研究表明,ALS病例的一个子集中存在遗传成分.
研究的目的:
- 为了确定临床人口中肌缩侧面硬化症 (ALS) 的遗传形式的发病率.
- 用下一代测序在患者中识别ALS相关的基因变异.
主要方法:
- 对374名确诊或可能患有ALS的患者进行了整体外基因组测序 (WES).
- 使用ALSoD数据库识别了与ALS相关的基因.
- 变种被分类为致病性/可能致病性 (P/LP) 或意义不明的变种 (VUS).
主要成果:
- 在54.01%的ALS患者中检测到遗传变异.
- 在8.29%的患者中发现了致病性/可能致病性 (P/LP) 变体.
- 与零星ALS (5.75%) 相比,在家族ALS (42.31%) 中,P/LP变体的检测显着更高.
- 不确定意义的变异 (VUS) 在零星ALS (47.13%) 中比家族ALS (23.07%) 更为普遍.
- 根据早期发病,快速进展,认知能力下降或小脑动症,没有观察到变异检测率的显著差异.
结论:
- 超过一半的研究ALS患者在ALS相关基因中存在变异,其中VUS是最常见的.
- 患有ALS的家族史是携带P/LP变体的强有力的指标.
- 临床指标,如早期发病,进展率,认知衰退或小脑动症,并不强烈地表明需要在临床实践中进行基因测试.
相关概念视频
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K


